Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Sven Schirmer · Senior Advisor, Health Canada (HC)
Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.Read more
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Discussions with ISED towards a national strategy for the biomanufacturing and the life sciences sector.Read more
Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.Read more
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.
Martin Moen · Associate Assistant Deputy Minister, Trade Policy and Negotiations, Global Affairs Canada (GAC)
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.Read more
Provide input into the Canada-United States-Mexico Agreement (CUSMA).
Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.Read more
Discussions with ISED towards a national strategy for the biomanufacturing and the life sciences sector.
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Maggie Chi · Parliamentary Secretary to the Minister of Health
Nora Draper · Parliamentary Secretary Assistant, Health Canada (HC)
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.Read more
Discussions with ISED towards a national strategy for the biomanufacturing and the life sciences sector.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Discussions with ISED towards a national strategy for the biomanufacturing and the life sciences sector.Read more
Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.Read more
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Provide input into the Canada-United States-Mexico Agreement (CUSMA).
Justine Frame · Policy Advisor, Health Canada (HC)
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.Read more
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Sven Schirmer · Senior Advisor, Health Canada (HC)
Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.Read more
Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Greg Orencsak · Deputy Minister, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.Read more
Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.
Seeking harmonization of regulatory regimes and administrative processes nationally and internationally.
Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.
Discussions with ISED towards a national strategy for the biomanufacturing and the life sciences sector.Read more
Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.
Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Seeking harmonization of regulatory regimes and administrative processes nationally and internationally.
Mélanie Joly · Minister of Industry and Minister Responsible for the Economic Development for Quebec Regions, Innovation, Science and Economic Development Canada (ISED)
Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.Read more
Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Discussions with ISED towards a national strategy for the biomanufacturing and the life sciences sector.Read more
Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.
Health Canada with respect to user fees for therapeutic product regulatory programs.
Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Greg Orencsak · Deputy Minister, Health Canada (HC)
Krista Urchenko · Senior Advisor, Health Canada (HC)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.Read more
Providing input with respect to the approval pathway for biosimilar medicines by Health Canada.
Health Canada with respect to user fees for therapeutic product regulatory programs.
Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.
Aaron Fowler · Chief Trade Negotiator and Associate Assistant Deputy Minister, Global Affairs Canada (GAC)
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.Read more
Provide input into the Canada-United States-Mexico Agreement (CUSMA).
Jeremy Bruce · Director, Canada-US Relations, Global Affairs Canada (GAC)
Nicholas Lovrics · Senior Advisor, Parliamentary Affairs and Issues Management, Global Affairs Canada (GAC)
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.Read more
Eshan Naik · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.Read more
Eshan Naik · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.Read more
Mark Holland · Minister of Health, Health Canada (HC)
Michelle Boudreau · Associate Assistant Deputy Minister, Health Canada (HC)
Linsey Hollett · A/Assistant Deputy Minister, Health Canada (HC)
Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.